Commitment to Clients
As a trusted advisor to clients, I work collaboratively with the board and senior management to ensure that compensation programs are optimally aligned with the business and support long-term value creation for stakeholders.
Biography
Rob is a managing director with Pearl Meyer with almost 15 years of experience in executive compensation and finance. He serves as a trusted advisor to boards and senior management at public and private firms across North America.
He works with companies in all industries, but he has in-depth knowledge and expertise in designing compensations strategies for organizations in life sciences and technology, particularly emerging and high growth companies that are pursuing or have recently completed a M&A transaction or public offering.
Prior to joining Pearl Meyer, Rob was a co-founding partner at Echelon Compensation Partners, an independent consulting firm specializing in executive and broad-based compensation at privately held and publicly traded companies, and a director at Farient Advisors in Los Angeles. He is a Certified Executive Compensation Professional, a distinction awarded by WorldatWork for excellence in the field, and a Certified Equity Professional, which is the only internationally recognized equity compensation designation focusing on taxation, accounting, securities laws, and administration of equity-based incentive programs.
Rob holds a BSc. with honors degree in international management with American business studies from the University of Manchester, UK.
Publications and Presentations By Robert James
![closeup of orange test tube tray with blue pipette](/sites/default/files/styles/insights_research_grid/public/images/content/GettyImages-177344969-closeup-of-orange-test-tube-tray-with-blue-pipette.jpg?itok=ZurgV9Sb)
Biopharma IPOs: Trends in Executive Compensation Planning and Design
![scientist prepares lab cultures for study](/sites/default/files/styles/insights_research_grid/public/images/content/GettyImages-1497915823-scientist-prepares-lab-cultures-for-study.jpg?itok=7d_E99-5)
Biopharma Fundraising and the Related Compensation Considerations
![close up of round yellow pills in blister pack](/sites/default/files/styles/insights_research_grid/public/GettyImages-a0139-000099-close-up-of-round-yellow-pills-in-blister-pack.jpg?itok=mvIJn1Of)
Key Considerations for Biopharma Equity Plan Amendments
![frederick douglass memorial bridge washington dc](/sites/default/files/styles/insights_research_grid/public/images/content/GettyImages-1455824039-frederick-douglass-memorial-bridge-washington-dc.jpg?itok=qtCEcy1A)